Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
927.20 DKK | +1.42% | +5.31% | +32.98% |
01:57am | Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production | RE |
12/09 | NOVO NORDISK : Deutsche Bank keeps its Buy rating | ZD |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Diabetes and Obesity Care | 10TCr | 11TCr | 12TCr | 16TCr | 22TCr | |||||
Total Assets | 8.67TCr | - | - | - | - | |||||
CAPEX | -964.4Cr | - | - | - | - | |||||
D&A | 391.6Cr | 462.4Cr | 489.5Cr | 570.1Cr | 819.5Cr | |||||
Operating Income | 4.26TCr | 4.37TCr | 4.95TCr | 6.74TCr | 9.96TCr | |||||
Rare Disease | 1.92TCr | 1.89TCr | 1.92TCr | 2.05TCr | 1.72TCr | |||||
Total Assets | 1.65TCr | - | - | - | - | |||||
CAPEX | -151.8Cr | - | - | - | - | |||||
D&A | 174.5Cr | 112.9Cr | 113Cr | 166.1Cr | 121.8Cr | |||||
Operating Income | 984.6Cr | 1.04TCr | 910.6Cr | 741.4Cr | 295.1Cr | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | 2.24TCr | - | - | - | - |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
The US | 5.75TCr | 5.78TCr | 6.3TCr | 8.47TCr | 13TCr | |||||
Total Assets | 3.95TCr | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EMEA | - | 3.43TCr | 3.77TCr | 4.42TCr | 5.09TCr | |||||
Rest of World | - | 1.74TCr | 1.98TCr | 2.54TCr | 2.81TCr | |||||
Region China | 1.28TCr | 1.41TCr | 1.6TCr | 1.62TCr | 1.67TCr | |||||
Total Assets | 682Cr | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
North America (Excl. US) | 297.1Cr | 329.3Cr | 425.4Cr | 645.1Cr | 909.5Cr | |||||
Total Assets | 61Cr | - | - | - | - | |||||
Africa, Asia, Middle East and Oceania (AAMEO) | 1.41TCr | - | - | - | - | |||||
Total Assets | 672.9Cr | - | - | - | - | |||||
Latin America | 491.6Cr | - | - | - | - | |||||
Total Assets | 344.2Cr | - | - | - | - | |||||
Pacific | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Japan & Korea | 645.3Cr | - | - | - | - | |||||
Total Assets | 154.3Cr | - | - | - | - | |||||
North America | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Europe | 2.33TCr | - | - | - | - | |||||
Total Assets | 6.7TCr | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
International Operations | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - |
- Stock Market
- Equities
- NOVO B Stock
- Financials Novo Nordisk A/S
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition